NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
urologix
Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Michael Bloomberg Proclaims “OneMedForum Days” in New York City
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
OneMedForum New York 2010 Successfully Brings Together Innovators and Investors
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Urologix and Uroplasty: Treatments for Common Urinary Disorders
Voiding the bladder is one of the most basic human functions, so mundane that we pay it little mind most of the time.